- Login
- Register & Subscribe
- Language: EN FR DE
Regulation & Policy
UK announces new drug pricing agreement
Thursday 20 November 2008
The UK Department of Health has reached an agreement with the pharmaceutical industry to change the way in which drugs are priced and supplied to the National Health Service (NHS).
Location
United Kingdom
Ban proposed on the use of great apes in research
Thursday 13 November 2008
The European Commission is proposing to ban the use of great apes in scientific research in a move to tighten up the regulation of animal studies.
Location
Belgium
Sanofi-aventis discontinues all trials of Acomplia
Friday 7 November 2008
Sanofi-aventis has stopped all clinical trials of Acomplia (rimonabant), which until recently had been sold on 32 markets around the world as a treatment for obesity. The trials were being conducted in order to investigate new indications for the drug in diabetes and heart disease.
Location
France
Three proprietary drugs of US firms cleared by the EMEA
Wednesday 29 October 2008
The European Medicines Agency is recommending new marketing authorisations for three proprietary medicinal products, one of which was cleared following an appeal. The EMEA’s recommendations are usually endorsed by the European Commission, which has the power to issue authorisations.
Location
United Kingdom
Sanofi-Aventis told to take obesity drug off the European market
Friday 24 October 2008
Sanofi-Aventis has been told by the European Medicines Agency that patients taking its obesity treatment, Acomplia (rimonabant), are at risk of depression. The agency is therefore recommending the drug be pulled from the European market.
Location
France
Editorial: the case for orphan antibiotics
Thursday 16 October 2008
Governments in the industrialised world have revolutionized drug development over the past 25 years with the introduction of orphan legislation encouraging companies to invest in new products to treat rare diseases. Legislation in the US, Europe, Japan and elsewhere gives incentives to companies to start looking after the medical needs of patients with rare, but life-threatening diseases. The concept of ‘orphan’ derives from the fact that these patients had previously been ‘orphaned’ by the pharmaceutical industry.
Location
United Kingdom
EMEA says it is giving more advice but marketing applications are steady
Friday 10 October 2008
The number of new applications for marketing authorisations in the first half of 2008 was steady compared with a year earlier, but requests for scientific advice increased by 28% over the same period, the European Medicines Agency said in its latest statistical overview of the pharmaceutical market.
Location
United Kingdom
EMEA and FDA expand their cooperation
Thursday 9 October 2008
The European Medicines Agency and the US Food and Drug Administration have agreed to expand the number of occasions on which they exchange confidential commercial data to include information about advanced-therapy medicines and medicines derived from nanotechnology as well as pharmacovigilance information.
Location
United Kingdom
EU governments urged to choose the most effective new medicines
Thursday 2 October 2008
Governments in the European Union are being urged to choose the most effective new medicines in deciding which products to subsidise under their publicly-funded health systems.
Location
Belgium
Consensus emerging on pharmaceutical innovation in Europe
Thursday 2 October 2008
Innovation has been a widely discussed topic in Europe ever since political leaders of the European Union pledged in March 2000 to invest heavily in knowledge-based industries to create new jobs and support the region’s high standard of living. So what does spending on innovation mean for the pharmaceutical industry?
Location
United Kingdom
Select a News Category
Recent Appointments
Steffen Thirstrup joins NDA Group
Monday June 10 2013
Tarquin Bennett-Coles joins Odgers Berndtson
Monday June 10 2013
Sandy Eisen becomes non-executive director at Phosphate Therapeutics
Thursday June 6 2013
Eric-Paul Paques to chair Grünenthal
Thursday June 6 2013
Charles DeCarli joins advisory board at DiaGenic
Thursday June 6 2013